AI in Oncology Market Growth, Trends and Forecast 2035

PUNE, India - Aug. 4, 2026 - PRLog -- AI in Oncology Market Set for Transformative Growth Through 2035

The global AI in oncology market was valued at USD 3.24 billion in 2025 and is projected to reach USD 34.81 billion by 2035, expanding at a CAGR of 26.8% during the forecast period.

Growing Focus on Early Cancer Detection Boosts AI Adoption

The growing emphasis on early cancer detection is accelerating AI adoption in oncology. AI-powered algorithms analyze pathology slides, medical imaging, genomic data, and electronic health records with high accuracy, helping clinicians detect cancer earlier, reduce diagnostic delays, and improve patient outcomes.

Precision Oncology Drives the Next Wave of Innovation

AI is transforming precision oncology by combining genomic, biomarker, imaging, and clinical data to support personalized treatment decisions. It also enables faster drug discovery, biomarker identification, optimized clinical trials, and improved treatment response prediction, driving innovation across the oncology ecosystem.
Get a Free Sample: https://www.cervicornconsulting.com/sample/2998

Digital Pathology and Medical Imaging Transform Cancer Diagnosis

AI-powered digital pathology and medical imaging improve cancer diagnosis by analyzing tissue samples and scans with greater speed and accuracy. These technologies help detect cancer earlier, reduce false positives, support pathologists, and enhance clinical efficiency.

Increasing Investments and Strategic Collaborations Fuel Market Growth

Growing investments from healthcare organizations, technology firms, pharmaceutical companies, and governments are accelerating AI innovation in oncology. Strategic partnerships are speeding up the development and commercialization of advanced AI-powered cancer care solutions.

Cloud Computing and Big Data Enhance AI Capabilities

Cloud computing and large healthcare datasets enable AI platforms to analyze medical imaging, genomic, and clinical data more efficiently. This supports real-time decision-making, continuous model improvement, and scalable, data-driven cancer care.

Top Companies Shaping the AI in Oncology Market

Leading companies such as Tempus AI, IBM, Siemens Healthineers, GE HealthCare, Microsoft, NVIDIA, PathAI, Paige AI, ConcertAI, and Illumina are driving innovation through AI, genomics, cloud computing, and digital pathology. Their investments in R&D, partnerships, and acquisitions are accelerating AI-enabled oncology solutions that improve cancer diagnosis, treatment planning, and patient outcomes.

North America Leads While Asia-Pacific Grows Rapidly

North America leads the AI in oncology market due to its advanced healthcare infrastructure, strong AI adoption, and presence of major industry players. Asia-Pacific is expected to grow the fastest, driven by rising cancer cases, expanding healthcare systems, increased digital health investments, and supportive government initiatives.
Read the complete report: https://www.cervicornconsulting.com/ai-in-oncology-market